Viatris Inc. logo
Viatris Inc. (VTRS)
Compare

Viatris Inc. (VTRS) Dividend Payout Ratio: 31.79%

Is Viatris Inc.’s dividend payout ratio high or low?

Viatris Inc.'s dividend payout ratio of 31.79% is 24% below its 5-year average of 41.63%, near the low end of its 5-year range (0.00%–328.59%).

As of Sunday, June 21, 2026. 1.63% above its 12-month average of 31.28%.

Dividend Payout Ratio (31.79%) = TTM Dividends/Share ($0.48) / TTM EPS ($1.51)

VTRS Dividend Payout Ratio Chart

VTRS Dividend Payout Ratio
31.79%-41.73% 1Y
Zoom

VTRS Average Dividend Payout Ratio Chart

VTRS Current vs Average Dividend Payout Ratio Chart

VTRS Dividend Payout Ratio Metrics

DIVIDEND PAYOUT RATIO

31.79%

DIVIDEND PAYOUT RATIO AVG TTM

31.28%

DIVIDEND PAYOUT RATIO AVG 3Y

49.90%

DIVIDEND PAYOUT RATIO AVG 5Y

21.89%

DIVIDEND PAYOUT RATIO AVG 10Y

0.00%

DIVIDEND PAYOUT RATIO AVG 15Y

N/A

DIVIDEND PAYOUT RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+1.63%

CURRENT VS 3Y AVG

-36.30%

CURRENT VS 5Y AVG

+45.19%

CURRENT VS 10Y AVG

+7140872919766303.00%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

Annual Payout Ratio History

YearEPSDividendPayout Ratio
2025($3.00)$0.48N/A (Loss)
2024($0.53)$0.48N/A (Loss)
2023$0.05$0.48N/A
2022$1.71$0.4828.1%
2021($1.05)$0.33N/A (Loss)
2020($1.11)$0.00N/A (Loss)
2019$0.03$0.000.0%
2018$0.69$0.000.0%
2017$1.30$0.000.0%
2016$0.94$0.000.0%
2015$1.80$0.000.0%
2014$2.49$0.000.0%
2013$1.63$0.000.0%
2012$1.54$0.000.0%
2011$1.25$0.000.0%
2010$0.69$0.000.0%
2009$0.31$0.000.0%
2008($0.64)$0.00N/A (Loss)
2007($5.90)$0.12N/A (Loss)
2006$0.80$0.2430.0%
2005$0.76$0.2127.6%
2004$1.24$0.129.7%

Viatris Inc. Dividend Payout Ratio Formula & Definition

The payout ratio shows the share of trailing-12-month earnings paid out as dividends. Lower leaves more room to grow the dividend; a ratio persistently above 100% means dividends exceed earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Viatris Inc. Dividend Payout Ratio FAQ

What is the dividend payout ratio for Viatris Inc. (VTRS)?
The dividend payout ratio for VTRS stock is 31.79%.
Is Viatris Inc.'s dividend payout ratio high or low?
Viatris Inc.'s dividend payout ratio of 31.79% is 24% below its 5-year average of 41.63%, near the low end of its 5-year range (0.00%–328.59%).
What is the TTM average dividend payout ratio for Viatris Inc. (VTRS)?
The TTM average dividend payout ratio for VTRS stock is 31.28%.
What is the 3Y average dividend payout ratio for Viatris Inc. (VTRS)?
The 3Y average dividend payout ratio for VTRS stock is 49.90%.
What is the 5Y average dividend payout ratio for Viatris Inc. (VTRS)?
The 5Y average dividend payout ratio for VTRS stock is 21.89%.
What is the 10Y average dividend payout ratio for Viatris Inc. (VTRS)?
The 10Y average dividend payout ratio for VTRS stock is 0.00%.

Viatris Inc. Dividend Payout Ratio History

DATEDIVIDEND PAYOUT RATIO
2024-02-2331.79%
2024-02-2131.78%
2024-02-1631.79%
2024-02-1431.77%
2024-02-1231.77%
2024-02-0831.81%
2024-02-0631.77%
2024-02-0231.80%
2024-01-3131.77%
2024-01-2931.80%
2024-01-2531.77%
2024-01-2331.77%
2024-01-1931.79%
2024-01-1731.79%
2024-01-1231.81%
2024-01-1031.78%
2024-01-0831.77%
2024-01-0431.79%
2024-01-0231.78%
2023-12-2831.81%
2023-12-2631.78%
2023-12-2131.77%
2023-12-1931.78%
2023-12-1531.78%
2023-12-1331.79%
2023-12-1131.79%
2023-12-0731.77%
2023-12-0531.77%
2023-12-0131.81%
2023-11-2931.81%
2023-11-2731.81%
2023-11-2231.81%
2023-11-2031.78%
2023-11-1631.77%
2023-11-1431.81%
2023-11-1031.77%
2023-11-0831.81%
2023-11-0631.37%
2023-11-0231.39%
2023-10-3131.39%
2023-10-2731.36%
2023-10-2531.36%
2023-10-2331.37%
2023-10-1931.35%
2023-10-1731.36%
2023-10-1331.38%
2023-10-1131.36%
2023-10-0931.35%
2023-10-0531.36%
2023-10-0331.39%
2023-09-2931.35%
2023-09-2731.38%
2023-09-2531.36%
2023-09-2131.36%
2023-09-1931.35%
2023-09-1531.39%
2023-09-1331.36%
2023-09-1131.36%
2023-09-0731.39%
2023-09-0531.37%
2023-08-3131.39%
2023-08-2931.37%
2023-08-2531.37%
2023-08-2331.37%
2023-08-2131.36%
2023-08-1731.37%
2023-08-1531.35%
2023-08-1131.38%
2023-08-0931.37%
2023-08-0731.37%
2023-08-0330.59%
2023-08-0130.58%
2023-07-2830.55%
2023-07-2630.60%
2023-07-2430.55%
2023-07-2030.58%
2023-07-1830.55%
2023-07-1430.57%
2023-07-1230.56%
2023-07-1030.55%
2023-07-0630.59%
2023-07-0330.58%
2023-06-2930.56%
2023-06-2730.55%
2023-06-2330.59%
2023-06-2130.58%
2023-06-1630.55%
2023-06-1430.59%
2023-06-1230.59%
2023-06-0830.55%
2023-06-0630.59%
2023-06-0230.56%
2023-05-3130.58%
2023-05-2630.56%
2023-05-2430.56%
2023-05-2230.56%
2023-05-1830.58%
2023-05-1630.58%
2023-05-1230.57%
2023-05-1030.58%
2023-05-0830.55%
2023-05-0428.04%
2023-05-0228.05%
2023-04-2828.09%
2023-04-2672.74%
2023-04-2472.75%
2023-04-2072.74%
2023-04-1872.73%
2023-04-1472.71%
2023-04-1272.73%
2023-04-1072.71%
2023-04-0572.73%
2023-04-0372.72%
2023-03-3072.70%
2023-03-2872.73%
2023-03-2472.75%
2023-03-2272.71%
2023-03-2072.71%
2023-03-1672.71%
2023-03-1472.71%
2023-03-1072.72%
2023-03-0872.73%
2023-03-0654.53%
2023-03-0254.53%
2023-02-2854.54%
2023-02-2454.55%
2023-02-2272.73%
2023-02-1772.72%
2023-02-1572.71%
2023-02-1372.72%
2023-02-0972.74%
2023-02-0772.73%
2023-02-0372.71%
2023-02-0172.74%
2023-01-3072.72%
2023-01-2672.74%
2023-01-2472.74%
2023-01-2072.74%
2023-01-1872.73%
2023-01-1372.71%
2023-01-1172.71%
2023-01-0972.74%
2023-01-0572.73%
2023-01-0372.72%
2022-12-2972.71%
2022-12-2772.74%
2022-12-2272.74%
2022-12-2072.72%
2022-12-1672.74%
2022-12-1472.72%
2022-12-1272.73%
2022-12-0872.74%
2022-12-0672.72%
2022-12-0272.71%
2022-11-3072.72%
2022-11-2872.74%
2022-11-2372.74%
2022-11-2171.20%
2022-11-1771.23%
2022-11-1571.21%
2022-11-1171.20%
2022-11-0971.22%
2022-11-0771.21%
2022-11-0374.61%
2022-11-0174.60%
2022-10-2874.58%
2022-10-2674.62%
2022-10-2474.62%
2022-10-2074.63%
2022-10-1874.58%
2022-10-1474.61%
2022-10-1274.58%
2022-10-1074.61%
2022-10-0674.60%
2022-10-0474.61%
2022-09-3074.58%
2022-09-2874.62%
2022-09-2674.60%
2022-09-2274.60%
2022-09-2074.61%
2022-09-1674.59%
2022-09-1474.61%
2022-09-1274.61%
2022-09-0874.63%
2022-09-0674.62%
2022-09-0174.60%
2022-08-3074.62%
2022-08-2674.59%
2022-08-2474.62%
2022-08-2273.02%
2022-08-1873.02%
2022-08-1673.00%
2022-08-1273.03%
2022-08-1073.04%
2022-08-0873.03%
2022-08-04328.55%
2022-08-02328.58%
2022-07-29328.55%
2022-07-27328.58%
2022-07-25328.56%
2022-07-21328.56%
2022-07-19328.58%
2022-07-15328.58%
2022-07-13328.59%
2022-07-11328.59%
2022-07-07328.58%
2022-07-05328.57%
2022-06-30328.59%
2022-06-28328.58%
2022-06-24328.59%
2022-06-22328.58%
2022-06-17328.55%
2022-06-15328.58%
2022-06-13328.58%
2022-06-09328.57%
2022-06-07328.58%
2022-06-03328.56%
2022-06-01328.56%
2022-05-27328.57%
2022-05-25328.57%
2022-05-23328.57%
2022-05-19321.43%
2022-05-17321.43%
2022-05-13321.42%
2022-05-11321.41%
2022-05-09321.44%
2021-02-260.00%
2021-02-240.00%
2021-02-220.00%
2021-02-180.00%
2021-02-160.00%
2021-02-110.00%
2021-02-090.00%
2021-02-050.00%
2021-02-030.00%
2021-02-010.00%
2021-01-280.00%
2021-01-260.00%
2021-01-220.00%
2021-01-200.00%
2021-01-150.00%
2021-01-130.00%
2021-01-110.00%
2021-01-070.00%
2021-01-050.00%
2020-12-310.00%
2020-12-290.00%
2020-12-240.00%
2020-12-220.00%
2020-12-180.00%
2020-12-160.00%
2020-12-140.00%
2020-12-100.00%
2020-12-080.00%
2020-12-040.00%
2020-12-020.00%
2020-11-300.00%
2020-11-250.00%
2020-11-230.00%
2020-11-190.00%

Showing the most recent 260 of 1,065 data points. The chart above shows the full history.

About Viatris Inc.

Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products, encompassing branded prescription medications, generic and complex generic drugs, biosimilar treatments, and active pharmaceutical ingredients (APIs). These offerings target diverse therapeutic areas, addressing both noncommunicable and infectious diseases. Its biosimilars specifically focus on critical conditions in oncology, immunology, endocrinology, ophthalmology, and dermatology. Furthermore, Viatris's APIs are utilized across numerous drug categories, including antibacterials, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitors. Beyond manufacturing medicines, Viatris supports patient well-being through additional services such as diagnostic clinics, educational seminars, and digital tools designed to assist with health management. Products are made available in various forms, including oral solids, injectable solutions, complex dosage formulations, and raw APIs. Viatris distributes these to a broad clientele globally, including retail pharmacies, wholesalers, government bodies, insurance providers, and institutional healthcare facilities. The distribution network involves pharmaceutical wholesalers, retail and institutional pharmacies, mail-order and e-commerce platforms, and specialty pharmacies. The company's extensive portfolio includes prominent brands like Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, Yupelri, Norvasc, Viagra, AMITIZA, Lipacreon, Effexor, Celebrex, and ARV. Its biosimilar franchises feature products such as Fulphila, Ogivri, Hulio, and SEMGLEE. Viatris Inc. also fosters innovation through strategic collaborations and licensing agreements with partners including Revance Therapeutics, Inc., Momenta Pharmaceuticals, Inc., Theravance Biopharma, Inc., Biocon Ltd., and Fujifilm Kyowa Kirin Biologics Co. Ltd. Founded in 1961, Viatris Inc. maintains its corporate headquarters in Canonsburg, Pennsylvania.

Canonsburg, PA
32,000 employees
Healthcare / Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Scott Andrew Smith